PILL - Direxion Daily Pharmaceutical & Medical Bull 3X Shares
| Assets | $13.69M |
| NAV | $19.55 |
| Expense Ratio | 0.98% |
| PE Ratio | 22.66 |
| Beta (5Y) | 3.13 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | Sep 24, 2019 |
| 1-Year Return | - |
| Trading Day | April 20 |
| Last Price | $19.49 |
| Previous Close | $19.65 |
| Change ($) | -0.16 |
| Change (%) | -0.81% |
| Day's Open | 19.34 |
| Day's Range | 18.94 - 19.78 |
| Day's Volume | 26,761 |
| 52-Week Range | 11.60 - 31.86 |
Fund Description
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
| Asset Class Equity | Inception Date Nov 15, 2017 |
| Exchange NYSEARCA | Ticker Symbol PILL |
| Index Tracked Dynamic Pharmaceutical Intellidex Index | |
Top 10 Holdings
81.85% of assets| Name | Symbol | Weight |
|---|---|---|
| S&P Pharmaceuticals Select Index SWAP | n/a | 52.35% |
| S&P PHARMACEUTICALS SELECT INDEX SWAP | n/a | 13.88% |
| BANK OF NEW YORK CASH RESERVE | n/a | 4.69% |
| GOLDMAN FINL SQ TRSRY INST 506 | n/a | 3.03% |
| S&P Pharmaceuticals Select Index SWAP | n/a | 1.83% |
| DREYFUS GOVT CASH MGMT | n/a | 1.78% |
| GOLDMAN FINL SQ TRSRY INS | n/a | 1.24% |
| Pfizer | PFE | 1.03% |
| Zoetis | ZTS | 1.02% |
| Bristol-Myers Squibb | BMY | 1.00% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 23, 2019 | $0.00 | Dec 31, 2019 |
| Sep 24, 2019 | $0.015 | Oct 1, 2019 |
| Jun 25, 2019 | $0.022 | Jul 2, 2019 |
| Mar 19, 2019 | $0.057 | Mar 26, 2019 |
| Dec 27, 2018 | $0.099 | Jan 4, 2019 |
| Sep 25, 2018 | $0.043 | Oct 2, 2018 |
These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration of buyers who have gathered around the same price level.
The Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL) is up about 20% the past month, which is making it an easy pill to swallow for traders looking to capitalize on this sub-sector of h...
Last week was upbeat for Wall Street, with the S&P 500 and Nasdaq recording their best weekly advancement since July, rising about 3.7% and 4.6%, respectively.
Last week witnessed a tug-of-war between bulls and bears.
The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidemic.
Forecasting the next funds to hit the ETF graveyard can be tricky as the decision to hit the “off” switch lies with the issuer, but a combination of low assets and weak volume usually is widely viewed a...
We have highlighted five leveraged equity ETFs that piled up more than 20% returns in October and could continue to be investors' darlings.
With pharmaceuticals stocks under intense political scrutiny this year, the Dynamic Pharmaceutical Intellidex Index (DZRTR) is lower by nearly 8% and is on pace for one of its worst annual performances ...